pandem
influenza
korea
also
epidem
aim
investig
whether
surviv
improv
set
recent
advanc
intens
care
unit
icu
manag
conduct
retrospect
analysi
acut
respiratori
failur
patient
influenza
pneumonia
respect
two
tertiari
referr
hospit
korea
total
patient
treat
signific
differ
sofa
score
icu
admiss
day
inhospit
mortal
significantli
lower
patient
compar
vs
p
multivari
analys
treatment
year
associ
greater
likelihood
surviv
compar
patient
treat
treat
one
seventh
like
die
adjust
clinic
variabl
hazard
ratio
mortal
confid
interv
p
improv
surviv
patient
underw
extracorpor
membran
oxygen
treatment
inhospit
mortal
vs
p
decreas
tidal
volum
mechan
ventil
median
mlkg
vs
median
mlkg
p
observ
world
health
organ
declar
global
influenza
pandem
influenza
viru
spread
rapidli
worldwid
korea
patient
confirm
pandem
die
pandem
period
patient
hospit
intens
care
unit
icu
influenzaassoci
pneumonia
acut
respiratori
distress
syndrom
ard
develop
ard
led
tremend
increas
mortal
rate
rang
among
critic
ill
patient
infect
multipl
aspect
icu
patient
manag
improv
recent
year
includ
widespread
applic
lower
tidal
volum
ventil
restrict
blood
transfus
reduc
sed
use
earli
mobil
appropri
intervent
patient
sepsi
also
lesson
learn
manag
patient
critic
ill
extracorpor
membran
oxygen
ecmo
therapi
appli
sever
ard
associ
infect
korea
also
influenza
season
domin
influenza
viru
hypothes
surviv
improv
patient
viral
infect
advanc
icu
manag
aim
investig
whether
treatment
outcom
improv
compar
patient
acut
respiratori
failur
well
treatment
modal
associ
favor
treatment
outcom
enrol
patient
age
year
diagnos
acut
respiratori
failur
admit
icu
samsung
medic
center
referr
hospit
seoul
korea
asan
medic
center
referr
hospit
seoul
korea
defin
acut
respiratori
failur
infect
requir
mechan
ventil
mv
support
data
collect
consecut
patient
novemb
februari
novemb
march
analyz
retrospect
patient
data
pandem
period
extract
multicent
cohort
investig
adult
patient
confirm
critic
ill
admit
icu
korean
tertiari
referr
hospit
among
critic
ill
patient
samsung
medic
center
asan
medic
center
databas
studi
includ
patient
acut
respiratori
failur
retrospect
studi
approv
institut
review
board
irb
samsung
medic
center
irb
applic
asan
medic
center
irb
applic
patient
inform
anonym
deidentifi
analysi
therefor
requir
inform
consent
waiv
patient
medic
record
review
clinic
data
extract
includ
demograph
characterist
bodi
mass
index
bmi
smoke
histori
diagnost
method
sequenti
organ
failur
assess
sofa
score
nosocomi
infect
comorbid
hypertens
diabet
mellitu
chronic
obstruct
pulmonari
diseas
copd
chronic
kidney
diseas
chronic
liver
diseas
current
previou
solid
organ
malign
use
sofa
score
assess
sever
patient
acut
physiolog
chronic
health
evalu
apach
ii
score
appropri
patient
transfer
outsid
hospit
extracorpor
membran
oxygen
ecmo
support
sofa
score
assess
upon
admiss
data
treatment
icu
also
extract
includ
antivir
agent
antibiot
corticosteroid
mv
set
fraction
inspir
oxygen
fio
posit
endexpiratori
pressur
peep
inspiratori
pressur
tidal
volum
predict
bodi
weight
neuromuscular
block
agent
prone
posit
nitric
oxid
continu
renal
replac
therapi
crrt
ecmo
predict
bodi
weight
calcul
use
follow
equat
predict
bodi
weight
kilogram
men
addit
document
outcom
patient
acut
respiratori
failur
includ
length
icu
hospit
stay
inhospit
mortal
data
present
median
interquartil
rang
iqr
continu
variabl
frequenc
percentag
categor
variabl
data
compar
mannwhitney
u
test
continu
variabl
pearson
chisquar
test
fisher
exact
test
categor
variabl
cox
proport
hazard
model
use
determin
whether
treatment
year
associ
surviv
evalu
factor
associ
favor
treatment
outcom
initi
clinic
variabl
enter
model
includ
age
sex
bmi
year
diabet
mellitu
solid
organ
malign
neuromuscular
blocker
prone
posit
nitric
oxid
ecmo
crrt
acut
kidney
injuri
test
twosid
p
consid
signific
data
analyz
use
ibm
spss
statist
window
version
armonk
ny
usa
patient
diagnos
acut
respiratori
failur
patient
samsung
medic
center
asan
medic
center
patient
diagnos
samsung
medic
center
asan
medic
center
clinic
data
patient
treat
includ
publish
articl
data
patient
previous
report
baselin
characterist
summar
tabl
median
age
patient
year
iqr
year
patient
male
patient
older
tabl
baselin
characterist
patient
acut
respiratori
failur
treatment
modal
outcom
summar
tabl
modal
includ
neuromuscular
block
agent
prone
posit
nitric
oxid
two
year
ecmo
use
n
patient
n
p
four
six
patient
treat
ecmo
transfer
outsid
hospit
ecmo
support
inhospit
mortal
significantli
lower
patient
treat
compar
treat
versu
p
signific
differ
length
stay
icu
hospit
two
year
tabl
shown
fig
cumul
surviv
rate
significantli
higher
acut
respiratori
failur
patient
compar
patient
one
seventh
like
die
adjust
clinic
variabl
hazard
ratio
hr
confid
interv
ci
p
addit
age
hr
ci
p
current
previou
solid
organ
malign
hr
ci
p
prone
posit
hr
ci
p
significantli
associ
mortal
tabl
characterist
treatment
modal
outcom
patient
receiv
ecmo
treatment
summar
tabl
patient
n
tend
younger
versu
year
p
higher
bmi
versu
kgm
p
n
although
neither
differ
statist
signific
admiss
day
signific
differ
sofa
score
versu
p
two
year
time
initi
ecmo
treatment
tidal
volum
predict
bodi
weight
versu
mlkg
p
fio
versu
p
significantli
lower
signific
differ
length
hospit
icu
stay
two
year
inhospit
mortal
versu
p
lower
studi
investig
whether
surviv
improv
patient
acut
respiratori
failur
advanc
icu
manag
sought
identifi
treatment
modal
use
epidem
pandem
inhospit
mortal
among
patient
improv
surviv
associ
treatment
year
though
associ
specif
treatment
modal
improv
treatment
outcom
mortal
studi
compar
mortal
rate
report
previou
studi
critic
ill
patient
infect
improv
surviv
might
relat
advanc
icu
manag
regard
mv
paramet
tidal
volum
lower
patient
influenza
season
compar
influenza
despit
statist
signific
may
impli
intensivist
tendenc
recogn
ard
time
manner
adher
low
tidal
volum
may
influenc
improv
surviv
studi
studi
prone
posit
seem
associ
increas
mortal
patient
acut
respiratori
failur
howev
might
result
phenomenon
prone
posit
implement
patient
suffer
sever
hypoxia
worst
clinic
set
addit
prone
posit
show
decreas
mortal
increas
ventilatorfre
day
patient
sever
ard
thu
cautiou
interpret
result
pandem
sever
institut
report
observ
data
suggest
ecmo
increas
surviv
sever
pneumonia
report
consist
find
proport
patient
receiv
ecmo
treatment
increas
addit
inhospit
mortal
receiv
ecmo
lower
although
signific
associ
improv
surviv
ecmo
cox
proport
hazard
model
ard
high
tidal
volum
mlkg
predict
bodi
weight
time
deoxygen
pao
mm
hg
longer
hour
associ
high
mortal
studi
notabl
tidal
volum
predict
bodi
weight
significantli
lower
patient
receiv
ecmo
might
explain
improv
surviv
thu
prompt
initi
ecmo
treatment
consid
refractori
hypoxia
reliev
convent
treatment
sever
pneumonia
studi
crrt
frequent
use
acut
kidney
injuri
howev
crrt
acut
kidney
injuri
associ
decreas
inhospit
mortal
find
align
previou
studi
report
earli
renal
replac
therapi
initi
strategi
associ
sever
acut
kidney
injuri
septic
shock
ard
also
observ
studi
reveal
longterm
risk
major
cardiovascular
event
icu
survivor
common
receiv
renal
replac
therapi
receiv
renal
replac
therapi
howev
sinc
studi
popul
receiv
crrt
studi
small
relev
studi
evalu
role
crrt
patient
aki
studi
need
confirm
role
crrt
treatment
outcom
popul
alway
chanc
endem
pandem
viral
infect
futur
outbreak
middl
east
respiratori
syndrom
coronaviru
korea
one
exampl
howev
unfortun
treatment
outcom
patient
sever
viral
pneumonia
pandem
period
reportedli
poor
without
definit
treatment
modal
perspect
studi
provid
valuabl
data
suggest
advanc
routin
icu
manag
may
improv
treatment
outcom
viral
infect
thu
invest
effort
improv
icu
care
crucial
improv
treatment
outcom
patient
sever
viral
infect
studi
sever
limit
first
retrospect
studi
conduct
two
referr
center
korea
second
sampl
size
small
patient
like
receiv
lower
tidal
volum
treatment
outcom
patient
receiv
ecmo
better
howev
factor
statist
signific
probabl
due
small
sampl
size
though
proven
studi
prompt
ecmo
lungprotect
ventil
may
led
advanc
icu
manag
result
improv
surviv
third
small
sampl
size
made
studi
prone
select
bia
multivari
analysi
might
enough
remov
select
bia
thu
futur
studi
larger
studi
popul
need
investig
specif
treatment
modal
improv
surviv
acut
respiratori
failur
patient
pneumonia
treatment
outcom
patient
acut
respiratori
failur
improv
two
tertiari
referr
center
south
korea
